Skip to main content

Stratagene and Strand to Co-Develop Software That Analyzes Systems Bio Pathways, GeneChip Arrays

NEW YORK, Dec. 8 (GenomeWeb News) - Stratagene and Strand Life Sciences plan to develop a suite of bioinformatics software to analyze systems biology-focused pathways and Affymetrix's new GeneChip microarrays, the companies said today.

 

Terms of the agreement call for the companies to co-design and -develop software, which will include Strand's Avadis technology. Stratagene will exclusively market and sell the two products"shortly,"the companies said.

As GenomeWeb News reporter in February, Affymetrix said it would use Stratagene software for GeneChip data analysis. As part of that non-exclusive license, Stratagene will develop a new software package, called ArrayAssist Lite, which will be offered as a standard statistical analysis tool for Affy arrays.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.